Total Synthesis of (+)-Guaymasol

Sophie Feuillastre; Olivier Piva

doi:10.1055/s-0034-1379480

Synlett, Inhaltsverzeichnis

Synlett 2014; 25(20): 2883-2886
DOI: 10.1055/s-0034-1379480

letter

Total Synthesis of (+)-Guaymasol

Sophie Feuillastre

Université de Lyon, Université Lyon 1, Institut de Chimie et de Biochimie Moléculaire et Supramoléculaire (ICBMS), UMR 5246 CNRS, Bat Raulin, 43, Bd du 11 novembre 1918, 69622 Villeurbanne cedex, France Fax: +33(4)72448136 eMail: piva@univ-lyon1.fr

,

Olivier Piva*

Université de Lyon, Université Lyon 1, Institut de Chimie et de Biochimie Moléculaire et Supramoléculaire (ICBMS), UMR 5246 CNRS, Bat Raulin, 43, Bd du 11 novembre 1918, 69622 Villeurbanne cedex, France Fax: +33(4)72448136 eMail: piva@univ-lyon1.fr

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

The synthesis of (+)-guaymasol has been achieved from O-methyl chavicol by using a sequence combining a cross-metathesis and an asymmetric dihydroxylation of the newly created double bond. The first step using Grubbs type II catalyst delivered an inseparable 88:12 mixture of E and Z isomers. After treatment with AD-mix-β and deprotection of the benzyl ether by hydrogenolysis, (+)-guaymasol was finally isolated in 84% de and 90% ee.

Key words

natural products - total synthesis - cross-metathesis - dihydroxylation - phenols

Volltext

Referenzen

References and Notes
1 Kornprobst J.-M In Substances Naturelles d’Origine Marine . Vol. 1. Tec&Doc Ed; Paris: 2005

2a Lebar MD, Heimbegner JL, Baker BJ. Nat. Prod. Rep. 2007; 24: 774
2b Costa Leal M, Puga J, Serodio J, Gomes NC. M, Calado R. PLoS ONE 2012; 7: e30580

3 Blunt JW, Copp BR, Keyzers RA, Munro MH. G, Prinsep MR. Nat. Prod. Rep. 2014; 31: 160 ; and references therein
4 Trischman JA, Jensen PR, Fenical W. Nat. Prod. Lett. 1998; 11: 279
5 Virolleaud MA, Menant C, Fenet B, Piva O. Tetrahedron Lett. 2006; 47: 5127
6 Lin Z, Marett L, Hughen RW, Flores M, Forteza I, Ammon MA, Concepcion GP, Espino S, Olivera BM, Rosenberg G, Haygood MG, Light AR, Schmidt EW. Bioorg. Med. Chem. Lett. 2013; 23: 4867
7 Fernandes RA, Bodas MS, Kumar P. Tetrahedron 2002; 58: 1223
8 Salim H, Piva O. Tetrahedron Lett. 2007; 48: 2059
9 Bourcet E, Fache F, Piva O. Eur. J. Org. Chem. 2010; 4075
10 Raffier L, Piva O. Eur. J. Org. Chem. 2013; 1124

11a Kotha S, Dipak MK. Tetrahedron 2012; 68: 397
11b Prunet J, Grimaud L In Metathesis in Natural Product Synthesis . Cossy J, Arseniyadis S, Meyer C. Wiley-VCH; Weinheim: 2010: 287

12 Richard J.-A, Yee NgS, Chen DY.-K In Modern Tools for the Synthesis of Complex Bioactive Molecules . Cossy J, Arseniyadis S. John Wiley & Sons; Hoboken: 2012: 155

13a Kolb HC, VanNieuwenhze MS, Sharpless KB. Chem. Rev. 1994; 94: 2483
13b Noe MC, Letavic MA, Snow SL. Org. React. 2005; 60: 109

14a Neisius NM, Plietker B. J. Org. Chem. 2008; 73: 3218
14b Beligny S, Eibauer S, Maechling S, Blechert S. Angew. Chem. 2006; 45: 1900

15 Mwangi MT, Schulz MD, Bowden NB. Org. Lett. 2009; 11: 33

16a Hong SH, Sanders DP, Lee CW, Grubbs RH. J. Am. Chem. Soc. 2005; 127: 17160
16b Czaban J, Schertzer BM, Grela K. Adv. Synth. Catal. 2013; 355: 1997

17 Manzini S, Poater A, Nelson DJ, Cavallo L, Slawin AM. Z, Nolan SP. Angew. Chem. Int. Ed. 2014; 53: 8995
18 Krohn K, Vukics K. Synthesis 2007; 2894
19 Olah GA, Narang SC. Tetrahedron 1982; 38: 2225

20a Scott AI. Q. Rev., Chem. Soc. 1965; 19: 1
20b Gresser MJ, Wales SM, Keller PA. Tetrahedron 2010; 66: 6965

21 See the Supporting Information.

22a Meek SJ, O’Brien RV, Llaveria J, Schrock RR, Hoveyda AH. Nature 2011; 471: 461
22b Deraedt C, d’Halluin M, Astruc D. Eur. J. Inorg. Chem. 2013; 4881
22c Fürstner A. Science 2013; 341: 1357

23a Wang C, Haeffner F, Schrock RR, Hoveyda AH. Angew. Chem. Int. Ed. 2013; 52: 1939
23b Wang C, Yu M, Kyle AF, Jakubec P, Dixon DJ, Schrock RR, Hoveyda AH. Chem. Eur. J. 2013; 19: 2726
23c Mann TJ, Speed AW. H, Schrock RR, Hoveyda AH. Angew. Chem. Int. Ed. 2013; 52: 8395

24a Keitz BK, Endo K, Herbert MB, Grubbs RH. J. Am. Chem. Soc. 2011; 133: 9686
24b Rosebrugh LE, Herbert MB, Marx VM, Keitz BK, Grubbs RH. J. Am. Chem. Soc. 2013; 135: 1276
24c Occhipinti G, Hansen FR, Törnroos KW, Jensen VR. J. Am. Chem. Soc. 2013; 135: 3331

25 Vassao DG, Gang DR, Koedula T, Jackson B, Pichersky E, Davin LB, Lewis NG. Org. Biomol. Chem. 2006; 4: 2733
26 Keitz BK, Endo K, Patel PR, Herbert MB, Grubbs RH. J. Am. Chem. Soc. 2012; 134: 693
27 Selected data: Compound 12a: Yield: 56% (104 mg from 500 mg of 5a over 3 steps); colourless oil. 1 H NMR (300 MHz, CDCl₃): δ = 0.89 (d, J = 6.6 Hz, 6 H), 1.54–1.75 (m, 1 H), 1.91 (t, J = 6.2 Hz, 2 H), 3.28 (d, J = 6.2 Hz, 2 H), 5.05 (s, 2 H), 5.38–5.62 (m, 2 H), 6.91 (d, J = 8.6 Hz, 2 H), 7.10 (d, J = 8.6 Hz, 2 H), 7.28–7.46 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 22.5, 28.6, 38.4, 42.0, 70.2, 114.9, 127.6, 128.0, 128.7, 129.5, 130.4, 130.6, 133.7, 137.4, 157.2. HRMS (CI): m/z [M + H]⁺ calcd for C₂₀H₂₄O: 281.1900; found: 281.1902. Compound 12b: Yield: 8% (14 mg from 500 mg of 5a); colourless oil. ¹H NMR (300 MHz, CDCl₃): δ = 0.94 (d, J = 6.6 Hz, 6 H), 1.60–1.75 (m, 1 H), 2.04 (t, J = 6.7 Hz, 2 H), 3.34 (d, J = 6.7 Hz, 2 H), 5.05 (s, 2 H), 5.41–5.67 (m, 2 H), 6.92 (d, J = 8.5 Hz, 2 H), 7.11 (d, J = 8.6 Hz, 2 H), 7.28–7.48 (m, 5 H). Compound (+)-13a: Yield: 85% (100 mg from 118 mg of 12a/12b); white solid; mp 81–83 °C; [α]_D +18.1 (c = 0.5, CHCl₃). ¹H NMR (300 MHz, CDCl₃): δ = 0.94 (d, J = 6.8 Hz, 3 H), 0.92 (d, J = 6.8 Hz, 3 H), 1.20–1.38 (m, 2 H), 1.40–1.59 (m, 1 H), 1.66–1.90 (m, 2 H, OH), 2.67 (dd, J = 13.8, 8.5 Hz, 1 H), 2.85 (dd, J = 13.8, 3.9 Hz, 1 H), 3.51–3.70 (m, 2 H), 5.05 (s, 2 H), 6.94 (d, J = 8.6 Hz, 2 H), 7.15 (d, J = 8.6 Hz, 2 H), 7.26–7.48 (m, 5 H). ¹³C NMR (100 MHz, CDCl₃): δ = 22.0, 23.8, 24.7, 39.5, 43.0, 70.2, 71.8, 75.6, 115.2, 127.6, 128.1, 128.7, 130.4, 130.5, 137.2, 157.7. HRMS (ESI): m/z [M + Na] calcd for C₂₀H₂₆NaO₃: 337.1774; found: 337.1769. Compound rac-13b: Yield: 6% (9 mg from 100 mg of 5b); white solid; mp 81–83 °C. ¹H NMR (300 MHz, CDCl₃): δ = 0.94 (d, J = 6.5 Hz, 3 H), 0.99 (d, J = 6.7 Hz, 3 H), 1.14–1.38 (m, 2 H), 1.41–1.60 (m, 1 H), 1.66–1.96 (m, 2 H), 2.66 (dd, J = 13.9, 9.6 Hz, 1 H), 2.79 (dd, J = 3.5, 13.9 Hz, 1 H), 3.69–3.87 (m, 2 H), 5.05 (s, 2 H), 6.94 (d, J = 8.6 Hz, 2 H), 7.15 (d, J = 8.6 Hz, 2 H), 7.28–7.47 (m, 5 H). Guaymasol (+)-1: Yield: 78% (55 mg from 100 mg of 13a); colourless oil; [α]_D +23.5 (c = 0.4, CHCl₃) {see ref. 4: [α]_D +30.4 (c = 1.1, CHCl₃)}. ¹H NMR (400 MHz, CDCl₃): δ = 0.92 (t, J = 6.9 Hz, 6 H), 1.20–1.37 (m, 1 H), 1.45–1.59 (m, 1 H), 1.74–1.91 (m, 1 H), 1.93 (s, 2 H), 2.66 (dd, J = 13.9, 8.5 Hz, 1 H), 2.83 (dd, J = 13.9, 3.9 Hz, 1 H), 3.52–3.64 (m, 2 H), 6.77 (d, J = 8.5 Hz, 2 H), 7.09 (d, J = 8.5 Hz, 2 H). ¹³C NMR (100 MHz, CDCl₃): δ = 22.0, 23.8, 24.7, 39.4, 42.9, 71.8, 75.6, 115.7, 130.0, 130.7, 154.5. HRMS (ESI): m/z [M + Na] calcd for C₁₃H₂₀NaO₃: 247.1305; found: 247.1297.

Zusatzmaterial

Supporting Information